1. Rang H, Dale M, Ritter and Flower R. Rang and Dale's Pharmacology: Edn 6; Elsevier Publication, New Delhi, pp665-668, 2007.
2. ICH Harmonized Tripartite Guideline: “Pharmaceutical Quality System” ICH Q10, (Switzerland 2008).
3. ICH- Harmonized Tripartite Guideline: “Pharmaceutical Development” ICH Q8 (R2), (Switzerland 2009).
4. Lawrence Y. Pharmaceutical quality by design: Product and process development, understanding and control. Pharm Res 25:781–791, 2008.
5. Lee S, Raw A, Yu. L. Significance of drug substance physiochemical properties in regulatory quality by design. In Drugs and the Pharmaceutical Sciences 78 (Preformulation in Solid Dosage Form Development), London: Informa Health- care,571–583, 2008 (http://doi.org/10.1007/s11095-007-9511-1).